Regionally perfused taurine. Part I. Minimizes lactic acidosis and preserves CKMB and myocardial contractility after ischemia/reperfusion.
Oriyanhan
Wnimunk
W
Kyoto University, Kyoto, Japan 606-8507.
Miyamoto
Tadaomi A
TA
Yamazaki
Kazuhiro
K
Miwa
Senri
S
Takaba
Kiyoaki
K
Ikeda
Tadashi
T
Komeda
Masashi
M
D000818:Animals; D002314:Cardioplegic Solutions; D002316:Cardiotonic Agents / Q000378:metabolism; D052279:Creatine Kinase, MB Form / Q000378:metabolism*; D004247:DNA / Q000378:metabolism; D007035:Hypothermia; D019344:Lactic Acid / Q000097:blood*; D008297:Male; D009200:Myocardial Contraction / Q000502:physiology*; D017202:Myocardial Ischemia; D009206:Myocardium / Q000378:metabolism*; D018384:Oxidative Stress; D010477:Perfusion; D051381:Rats; D017207:Rats, Sprague-Dawley; D013223:Statistics as Topic; D013654:Taurine / Q000008:administration & dosage / Q000378:metabolism*
D002314:Cardioplegic Solutions; D002316:Cardiotonic Agents; D013654:Taurine; D019344:Lactic Acid; D004247:DNA; D052279:Creatine Kinase, MB Form